-
Posted by
Two Blokes May 16 -
Filed in
Stock
-
3 views
Net revenue increased 8.5% y/y, EBITDA margin also improved due to the diversified model, which supported cost control. NYSE listing could unlock repricing of multiples (EV/EBITDA of 6.15x vs. 8.3x of peers). An upside of almost 35%. Risks include high commodity prices and disappointment if the listing does not materialize.
